60
Participants
Start Date
September 30, 2006
Study Completion Date
September 30, 2008
ATN-224
Temozolomide
Center for Cancer and Blood Disorders, Bethesda
The Harry and Jeanette Weinberg Cancer Institute at Franklin Square, Baltimore
Cancer Center of the Carolinas, Greenville
Florida Cancer Specialists, Fort Myers
Tennessee Oncology, Nashville
Oncology Hematology Care, Cincinati
Billings Clinic, Billings
Hematology and Oncology Specialists, LLC, Metairie
Mary Crowley Medical Research Center, Dallas
University of Colorado Health Science Center, Denver
Arizona Cancer Center, Tucson
The Angeles Clinic, Santa Monica
Pacific Oncology and Hematology, Encinitas
Hematology - Oncology Group of Orange, Inc., Orange
UCI Chao Family Comprehensive Cancer Center, Orange
Mountainside Hospital Cancer Center - The Melanoma Center, Montclair
Chattanooga Oncology and Hematology Associates, Chattanooga
Lead Sponsor
Attenuon
INDUSTRY